Publications for Paul Haber
Publications for Paul Haber
2016
Connor, J., Haber, P., Hall, W. (2016). Alcohol
use disorders. The Lancet, 387(10022), 988-998.
<a
href="http://dx.doi.org/10.1016/S0140-6736(15)
00122-1">[More Information]</a>
Liangpunsakul, S., Haber, P., McCaughan, G.
(2016). Alcoholic Liver Disease in Asia, Europe,
and North America. Gastroenterology, 150(8),
1786-1797. <a
href="http://dx.doi.org/10.1053/j.gastro.2016.02.
043">[More Information]</a>
White, B., Haber, P., Day, C. (2016).
Community attitudes towards harm reduction
services and a newly established needle and
syringe automatic dispensing machine in an
inner-city area of Sydney, Australia.
International Journal of Drug Policy, 27,
121-126. <a
href="http://dx.doi.org/10.1016/j.drugpo.2015.05
.010">[More Information]</a>
Day, C., Shanahan, M., Wand, H., Topp, L.,
Haber, P., Rodgers, C., Deacon, R., Walsh, N.,
Kaldor, J., Van Beek, I., et al (2016).
Development of immunity following financial
incentives for hepatitis B vaccination among
people who inject drugs: A randomized
controlled trial. Journal Of Clinical Virology, 74,
66-72. <a
href="http://dx.doi.org/10.1016/j.jcv.2015.11.03
1">[More Information]</a>
Sheynin, J., Moustafa, A., Beck, K., Servatius,
R., Casbolt, P., Haber, P., Elsayed, M., Hogarth,
L., Myers, C. (2016). Exaggerated acquisition
and resistance to extinction of avoidance
behavior in treated heroin-dependent men.
Journal of Clinical Psychiatry, 77(3), 386-394.
<a
href="http://dx.doi.org/10.4088/JCP.14m09284"
>[More Information]</a>
Myers, C., Sheynin, J., Balsdon, T., Luzardo, A.,
Beck, K., Hogarth, L., Haber, P., Moustafa, A.
(2016). Probabilistic reward- and
punishment-based learning in opioid addiction:
Experimental and computational data.
Behavioural Brain Research, 296, 240-248. <a
href="http://dx.doi.org/10.1016/j.bbr.2015.09.01
8">[More Information]</a>
Grebely, J., Alavi, M., Micallef, M., Dunlop, A.,
Balcomb, A., Phung, N., Weltman, M., Day, C.,
Treloar, C., Bath, N., Haber, P., et al (2016).
Treatment for hepatitis C virus infection among
people who inject drugs attending opioid
substitution treatment and community health
clinics: The ETHOS Study. Addiction, 111(2),
311-319. <a
href="http://dx.doi.org/10.1111/add.13197">[Mo
re Information]</a>
2015
Gale, M., Muscatello, D., Dinh, M., Byrnes, J.,
Shakeshaft, A., Hayen, A., MacIntyre, C., Haber,
P., Cretikos, M., Morton, P. (2015). Alcopops,
taxation and harm: a segmented time series
analysis of emergency department presentations.
BMC Public Health, 15(1), 468. <a
href="http://dx.doi.org/10.1186/s12889-015-176
9-3">[More Information]</a>
Keats, J., Micallef, M., Grebely, J., Hazelwood,
S., Everingham, H., Hazelwood, S., Jones, T.,
Bath, N., Treloar, C., Dore, G., et al (2015).
Assessment and delivery of treatment for
hepatitis C virus infection in an opioid
substitution treatment clinic with integrated
peer-based support in Newcastle, Australia.
International Journal of Drug Policy, 26(10),
999-1006. <a
href="http://dx.doi.org/10.1016/j.drugpo.2015.07
.006">[More Information]</a>
Islam, M., Haber, P. (2015). Benzodiazepines.
In Paul Haber, Carolyn Day, Michael Farrell
(Eds.), Addiction Medicine: Principles and
Practice, (pp. 353-366). Melbourne: IP
Communications.
Whitfield, J., Rahman, K., Haber, P., Day, C.,
Masson, S., Daly, A., Cordell, H., Mueller, S.,
Seitz, H., Liangpunsakul, S., Seth, D., et al
(2015). Brief report: Genetics of alcoholic
Cirrhosis-GenomALC multinational study.
Alcoholism: Clinical and Experimental
Research, 39(5), 836-842. <a
href="http://dx.doi.org/10.1111/acer.12693">[M
ore Information]</a>
Meikle, P., Mundra, P., Wong, G., Rahman, K.,
Huynh, K., Barlow, C., Duly, A., Haber, P.,
Whitfield, J., Seth, D. (2015). Circulating Lipids
Are Associated with Alcoholic Liver Cirrhosis
and Represent Potential Biomarkers for Risk
Assessment. PloS One, 10(6), 1-13. <a
href="http://dx.doi.org/10.1371/journal.pone.013
0346">[More Information]</a>
Paull, P., Haber, P., Seth, D. (2015). Drug testing
and biomarkers of alcohol consumption. In Paul
Haber, Carolyn Day, Michael Farrell (Eds.),
Addiction Medicine: Principles and Practice,
(pp. 143-162). Melbourne: IP Communications.
Duly, A., Alani, B., Huang, E., Yee, C., Haber,
P., McLennan, S., Seth, D. (2015). Effect of
multiple binge alcohol on diet-induced liver
injury in a mouse model of obesity. Nutrition
and Diabetes, 5, 1-9.
Alavi, M., Micallef, M., Fortier, E., Dunlop, A.,
Balcomb, A., Day, C., Treloar, C., Bath, N.,
Haber, P., Dore, G., et al (2015). Effect of
Publications for Paul Haber
treatment willingness on specialist assessment
and treatment uptake for hepatitis C virus
infection among people who use drugs: The
ETHOS study. Journal of Viral Hepatitis,
22(11), 914-925. <a
href="http://dx.doi.org/10.1111/jvh.12415">[Mo
re Information]</a>
Blanch, B., Buckley, N., Mellish, L., Dawson,
A., Haber, P., Pearson, S. (2015). Harmonizing
post-market surveillance of prescription drug
misuse: a systematic review of observational
studies using routinely collected data
(2000-2013). Drug Safety, 38(6), 553-564. <a
href="http://dx.doi.org/10.1007/s40264-015-029
4-8">[More Information]</a>
Haber, P., Day, C., Topp, L., Shanahan, M.,
Wand, H., van Beek, I., Maher, L. (2015).
Hepatitis B vaccination for people who inject
drugs. The Lancet, 385(9963), 115. <a
href="http://dx.doi.org/10.1016/S0140-6736(15)
60019-8">[More Information]</a>
Hermens, D., Chitty, K., Lee, R., Tickell (nee
Kennedy), A., Haber, P., Naismith, S., Hickie, I.,
Lagopoulos, J. (2015). Hippocampal glutamate is
increased and associated with risky drinking in
young adults with major depression. Journal of
Affective Disorders, 186, 95-98. <a
href="http://dx.doi.org/10.1016/j.jad.2015.07.00
9">[More Information]</a>
Alavi, M., Spelman, T., Matthews, G., Haber, P.,
Day, C., Van Beek, I., Walsh, N., Yeung, B.,
Bruneau, J., Petoumenos, K., et al (2015).
Injecting risk behaviours following treatment for
hepatitis C virus infection among people who
inject drugs: The Australian Trial in Acute
Hepatitis C. International Journal of Drug
Policy, 26(10), 976-983. <a
href="http://dx.doi.org/10.1016/j.drugpo.2015.05
.003">[More Information]</a>
Wang, D., Lintzeris, N., Leung, S., Haber, P.,
Yee, B., Grunstein, R. (2015). Reversal of
central sleep apnoea with change from
methadone to buprenorphine-naloxone: a case
report. European Respiratory Journal, 46(4),
1202-1205. <a
href="http://dx.doi.org/10.1183/13993003.00577
-2014">[More Information]</a>
Stapinski, L., Rapee, R., Sannibale, C., Teesson,
M., Haber, P., Baillie, A. (2015). The Clinical
and Theoretical Basis for Integrated Cognitive
Behavioral Treatment of Comorbid Social
Anxiety and Alcohol Use Disorders. Cognitive
and Behavioral Practice, 22(4), 506-521. <a
href="http://dx.doi.org/10.1016/j.cbpra.2014.05.
004">[More Information]</a>
Fortier, E., Alavi, M., Micallef, M., Dunlop, A.,
Balcomb, A., Day, C., Treloar, C., Bath, N.,
Haber, P., Dore, G., et al (2015). The effect of
social functioning and living arrangement on
treatment intent, specialist assessment and
treatment uptake for hepatitis C virus infection
among people with a history of injecting drug
use: The ETHOS study. International Journal of
Drug Policy, 26(11), 1094-1102. <a
href="http://dx.doi.org/10.1016/j.drugpo.2015.06
.001">[More Information]</a>
Haber, P. (2015). Volatile substance use. In
Paul Haber, Carolyn Day, Michael Farrell (Eds.),
Addiction Medicine: Principles and Practice,
(pp. 367-372). Melbourne: IP Communications.
2014
Yap, L., Carruthers, S., Thompson, S., Cheng,
W., Jones, J., Simpson, P., Richards, A., Thein,
H., Haber, P., Lloyd, A., et al (2014). A
descriptive model of patient readiness,
motivators, and hepatitis C treatment uptake
among Australian prisoners. PloS One, 9(2),
1-11. <a
href="http://dx.doi.org/10.1371/journal.pone.008
7564">[More Information]</a>
Jaworowski, S., Walter, G., Soh, N., Freier Dror,
Y., Mergui, J., Gropp, C., Haber, P. (2014). A
validated questionnaire to assess the knowledge
of psychiatric aspects of alcohol use disorder.
Substance Abuse, 35(2), 147-152. <a
href="http://dx.doi.org/10.1080/08897077.2013.
822053">[More Information]</a>
Blanch, B., Pearson, S., Haber, P. (2014). An
overview of the patterns of prescription opioid
use, costs and related harms in Australia. British
Journal of Clinical Pharmacology, 78(5),
1159-1166. <a
href="http://dx.doi.org/10.1111/bcp.12446">[Mo
re Information]</a>
Morley, K., Baillie, A., Leung, S., Addolorato,
G., Leggio, L., Haber, P. (2014). Baclofen for the
Treatment of Alcohol Dependence and Possible
Role of Comorbid Anxiety. Alcohol and
Alcoholism, 49(6), 654-660. <a
href="http://dx.doi.org/10.1093/alcalc/agu062">[
More Information]</a>
Seth, D., Duly, A., Kuo, P., McCaughan, G.,
Haber, P. (2014). Osteopontin is an important
mediator of alcoholic liver disease via hepatic
stellate cell activation. World Journal of
Gastroenterology, 20(36), 13088-13104. <a
href="http://dx.doi.org/10.3748/wjg.v20.i36.130
88">[More Information]</a>
Haber, P., Day, C. (2014). Overview of
Substance Use and Treatment from Australia.
Substance Abuse, 35(3), 304-308. <a
href="http://dx.doi.org/10.1080/08897077.2014.
924466">[More Information]</a>
Keane, F., Yao, T., Seelk, S., Gall, M.,
Chowdhury, S., Poplawski, S., Lai, J., Li, Y.,
Publications for Paul Haber
Wu, W., Farrell, P., Vieira de Ribeiro, A.,
Osborne, B., Yu, M., Seth, D., Haber, P., Wang,
C., Thomson, S., Twigg, S., McLennan, S.,
McCaughan, G., Gorrell, M., et al (2014).
Quantitation of fibroblast activation protein
(FAP)-specific protease activity in mouse,
baboon and human fluids and organs. FEBS
Open Bio, 4, 43-54. <a
href="http://dx.doi.org/10.1016/j.fob.2013.12.00
1">[More Information]</a>
Morley, K., Sitharthan, G., Haber, P., Tucker, P.,
Sitharthan, T. (2014). The Efficacy of an
Opportunistic Cognitive Behavioral Intervention
Package (OCB) on Substance Use and Comorbid
Suicide Risk: A Multisite Randomized
Controlled Trial. Journal of Consulting and
Clinical Psychology, 82(1), 130-140. <a
href="http://dx.doi.org/10.1037/a0035310">[Mo
re Information]</a>
Islam, M., Conigrave, K., Day, C., Nguyen, Y.,
Haber, P. (2014). Twenty-year trends in
benzodiazepine dispensing in the Australian
population. Internal Medicine Journal, 44(1),
57-64. <a
href="http://dx.doi.org/10.1111/imj.12315">[Mo
re Information]</a>
2013
Topp, L., Day, C., Wand, H., Deacon, R., Van
Beek, I., Haber, P., Shanahan, M., Rodgers, C.,
Maher, L. (2013). A randomised controlled trial
of �?nancial incentives to increase hepatitis B
vaccination completion among people who inject
drugs in Australia. Preventive Medicine, 57(4),
297-303. <a
href="http://dx.doi.org/10.1016/j.ypmed.2013.04
.013">[More Information]</a>
Baille, A., Sannibale, C., Stapinski, L., Teesson,
M., Rapee, R., Haber, P. (2013). An
investigator-blinded, randomized study to
compare the efficacy of combined CBT for
alcohol use disorders and social anxiety disorder
versus CBT focused on alcohol alone in adults
with comorbid disorders: the Combined Alcohol
Social Phobia (CASP) trial protocol. BMC
Psychiatry, 13(7), 1-12. <a
href="http://dx.doi.org/10.1186/1471-244X-13-1
99">[More Information]</a>
Islam, M., Topp, L., Conigrave, K., White, A.,
Haber, P., Day, C. (2013). Are primary health
care centres that target injecting drug users
attracting and serving the clients they are
designed for? A case study from Sydney,
Australia. International Journal of Drug Policy,
24(4), 326-332. <a
href="http://dx.doi.org/10.1016/j.drugpo.2012.06
.002">[More Information]</a>
Alavi, M., Grebely, J., Micallef, M., Dunlop, A.,
Balcomb, A., Day, C., Treloar, C., Bath, N.,
Haber, P., Dore, G. (2013). Assessment and
Treatment of Hepatitis C Virus Infection Among
People Who Inject Drugs in the Opioid
Substitution Setting: ETHOS Study. Clinical
Infectious Diseases, 57(Suppl 2), S62-S69. <a
href="http://dx.doi.org/10.1093/cid/cit305">[Mo
re Information]</a>
Lakshman, M., Garige, M., Gong, M., Leckey,
L., Varatharajalu, R., Redman, R., Seth, D.,
Haber, P., Hirsch, K., Amdur, R., et al (2013).
CYP2E1, Oxidative Stress, Post-translational
Modifications and Lipid Metabolism. In
Aparajita Dey (Eds.), Cytochrome P450 2E1: Its
Role in Disease and Drug Metabolism, (pp.
199-233). Dordrecht: Springer Science+Business
Media.
Morley, K., Baillie, A., Sannibale, C., Teesson,
M., Haber, P. (2013). Integrated care for
comorbid alcohol dependence and anxiety and/or
depressive disorder: study protocol for an
assessor-blind, randomized controlled trial.
Addiction Science & Clinical Practice, 8, 1-8. <a
href="http://dx.doi.org/10.1186/1940-0640-8-19"
>[More Information]</a>
Buckley, V., Razaghi, A., Haber, P. (2013).
Predictors of neonatal outcomes amongst a
methadone- and/or heroin-dependent population
referred to a multidisciplinary Perinatal and
Family Drug Health Service. Australian and New
Zealand Journal of Obstetrics and Gynaecology,
53(5), 464-470. <a
href="http://dx.doi.org/10.1111/ajo.12080">[Mo
re Information]</a>
Islam, M., Topp, L., Conigrave, K., Haber, P.,
White, A., Day, C. (2013). Sexually transmitted
infections, sexual risk behaviours and perceived
barriers to safe sex among drug users. Australian
and New Zealand Journal of Public Health,
37(4), 311-315. <a
href="http://dx.doi.org/10.1111/1753-6405.1207
7">[More Information]</a>
Morley, K., Leung, S., Baillie, A., Haber, P.
(2013). The efficacy and biobehavioural basis of
baclofen in the treatment of alcoholic liver
disease (BacALD): Study protocol for a
randomised controlled trial. Contemporary
Clinical Trials, 36(2), 348-355. <a
href="http://dx.doi.org/10.1016/j.cct.2013.08.002
">[More Information]</a>
2012
Taylor, L., Hutchinson, D., Rapee, R., Burns, L.,
Stephens, C., Haber, P. (2012). Clinical Features
and Correlates of Outcomes for High-Risk,
Marginalized Mothers and Newborn Infants
Engaged with a Specialist Perinatal and Family
Drug Health Service. Obstetrics and Gynecology
International, 2012, 1-8. <a
href="http://dx.doi.org/10.1155/2012/867265">[
Publications for Paul Haber
More Information]</a>
Morley, K., Haber, P., Sitharthan, G., Tucker, P.,
Sitharthan, T. (2012). Clinical Predictors of
Suicidal Behaviour Among Patients with
Alcohol and/or Substance Abuse and Suicide
Risk. APSAD Conference, Australasian
Professional Society on Alcohol and other
Drugs, Melbourne.
Deacon, R., Topp, L., Wand, H., Day, C.,
Rodgers, C., Haber, P., van Beek, I., Maher, L.
(2012). Correlates of Susceptibility to Hepatitis
B among People Who Inject Drugs in Sydney,
Australia. Journal of Urban Health, 89(5),
769-778. <a
href="http://dx.doi.org/10.1007/s11524-012-968
0-z">[More Information]</a>
Schwarz, B., Haber, P. (2012). Detection and
management of problem drinking in general
practice. Medicine Today, 13(7), 44-52.
Alavi, M., Grebely, J., Matthews, G.,
Petoumenos, K., Yeung, B., Day, C., Lloyd, A.,
van Beek, I., Kaldor, J., Hellard, M., Haber, P.,
et al (2012). Effect of pegylated interferon
alfa-2a treatment on mental health during recent
hepatitis C virus infection. Journal of
Gastroenterology and Hepatology, 27(5),
957-965. <a
href="http://dx.doi.org/10.1111/j.1440-1746.201
1.07035.x">[More Information]</a>
Gidding, H., Law, M., Amin, J., Ostapowicz, G.,
Weltman, M., Macdonald, G., Sasadeusz, J.,
Haber, P., George, J., Dore, G. (2012). Hepatitis
C treatment outcomes in Australian clinics.
Medical Journal of Australia, 196(10), 633-637.
<a
href="http://dx.doi.org/10.5694/mja12.10014">[
More Information]</a>
Day, C., Demirkol, A., Tynan, M., Curry, K.,
Hines, S., Lintzeris, N., Haber, P. (2012).
Individual versus team-based case-management
for clients of opioid treatment services: An initial
evaluation of what clients prefer. Drug and
Alcohol Review, 31(4), 499-506. <a
href="http://dx.doi.org/10.1111/j.1465-3362.201
1.00347.x">[More Information]</a>
Islam, M., Topp, L., Conigrave, K., White, A.,
Reid, S., Grummett, S., Haber, P., Day, C.
(2012). Linkage into specialist hepatitis C
treatment services of injecting drug users
attending a needle syringe program-based
primary healthcare centre. Journal of Substance
Abuse Treatment, 43(4), 440-445. <a
href="http://dx.doi.org/10.1016/j.jsat.2012.07.00
7">[More Information]</a>
Black, K., Haber, P., Lintzeris, N. (2012).
Offering incentives to drug-using women to take
up contraception: The ethical and clinical issues.
Addiction, 107(7), 1361-1362. <a
href="http://dx.doi.org/10.1111/j.1360-0443.201
2.03873.x">[More Information]</a>
Mofizul Islam, M., Reid, S., White, A.,
Grummett, S., Conigrave, K., Haber, P. (2012).
Opportunistic and continuing health care for
injecting drug users from a nurse-run needle
syringe program-based primary health-care
clinic. Drug and Alcohol Review, 31(1), 114-115.
<a
href="http://dx.doi.org/10.1111/j.1465-3362.201
1.00390.x">[More Information]</a>
Morley, K., Haber, P., Morgan, M., Samara, F.
(2012). Pericyazine in the treatment of cannabis
dependence in general practice: a naturalistic
pilot trial. Substance Abuse and Rehabilitation,
3, 43-47. <a
href="http://dx.doi.org/10.2147/SAR.S30052">[
More Information]</a>
Black, K., Stephens, C., Haber, P., Lintzeris, N.
(2012). Unplanned pregnancy and contraceptive
use in women attending drug treatment services.
Australian and New Zealand Journal of
Obstetrics and Gynaecology, 52(2), 146-150. <a
href="http://dx.doi.org/10.1111/j.1479-828X.201
2.01413.x">[More Information]</a>
2011
Mofizul Islam, M., Grummett, S., White, A.,
Reid, S., Day, C., Haber, P. (2011). A primary
healthcare clinic in a needle syringe program
may contribute to HIV prevention by early
detection of incident HIV in an injecting drug
user. Australian and New Zealand Journal of
Public Health, 35(3), 294-295. <a
href="http://dx.doi.org/10.1111/j.1753-6405.201
1.00708.x">[More Information]</a>
Grebely, J., Matthews, G., Hellard, M., Shaw,
D., van Beek, I., Petoumenos, K., Alavi, M.,
Yeung, B., Haber, P., Lloyd, A., et al (2011).
Adherence to treatment for recently acquired
hepatitis C virus (HCV) infection among
injecting drug users. Journal of Hepatology,
55(1), 76-85. <a
href="http://dx.doi.org/10.1016/j.jhep.2010.10.0
33">[More Information]</a>
Day, C., Mofizul Islam, M., White, A., Reid, S.,
Hayes, S., Haber, P. (2011). Development of a
nurse-led primary healthcare service for injecting
drug users in inner-city Sydney. Australian
Journal of Primary Health, 17(1), 10-15. <a
href="http://dx.doi.org/10.1071/PY10064">[Mor
e Information]</a>
Haber, P. (2011). Gastrointestinal disorders
related to alcohol and other drug use. In
Christopher A. Cavacuiti (Eds.), Principles of
Addiction Medicine: The Essentials, (pp. 0-0).
United States: Lippincott Williams & Wilkins.
Publications for Paul Haber
Haber, P. (2011). International perspectives in
postgraduate medical training in addiction
medicine. Substance Abuse, 32(2), 75-76. <a
href="http://dx.doi.org/10.1080/08897077.2011.
555695">[More Information]</a>
Haber, P., Batey, R. (2011). Liver disorders
related to alcohol and other drug use. In
Christopher A. Cavacuiti (Eds.), Principles of
Addiction Medicine: The Essentials, (pp. 0-0).
United States: Lippincott Williams & Wilkins.
Seth, D., Haber, P., Syn, W., Diehl, A., Day, C.
(2011). Pathogenesis of alcohol-induced liver
disease: Classical concepts and recent advances.
Journal of Gastroenterology and Hepatology,
26(7), 1089-1105. <a
href="http://dx.doi.org/10.1111/j.1440-1746.201
1.06756.x">[More Information]</a>
Demirkol, A., Haber, P., Conigrave, K. (2011).
Problem drinking - detection and assessment in
general practice. Australian Family Physician,
40(8), 570-574. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21814650">[More Information]</a>
Demirkol, A., Conigrave, K., Haber, P. (2011).
Problem drinking - management in general
practice. Australian Family Physician, 40(8),
576-582. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21814651">[More Information]</a>
Burns, L., Conroy, E., Moore, E., Hutchinson,
D., Haber, P. (2011). Psychosocial
Characteristics and Obstetric Health of Women
Attending a Specialist Substance Use Antenatal
Clinic in a Large Metropolitan Hospital.
International Journal of Pediatrics, 2011
(Article ID 729237), 1-7. <a
href="http://dx.doi.org/10.1155/2011/729237">[
More Information]</a>
Haber, P., Murnion, B. (2011). Training in
Addiction Medicine in Australia. Substance
Abuse, 32(2), 115-119. <a
href="http://dx.doi.org/10.1080/08897077.2011.
555718">[More Information]</a>
Lipworth, W., Wodak, A., Haber, P., Day, R.
(2011). Why is Disulfiram not on the PBS?
Medical Journal of Australia, 195(7), 371-372.
<a
href="http://dx.doi.org/10.5694/mja11.10708">[
More Information]</a>
2010
Seth, D., El-Guindy, N., Apte, M., Mari, M.,
Dooley, S., Neuman, M., Haber, P., Kundu, G.,
Darwanto, A., De Villiers, W., et al (2010).
Alcohol, Signaling, and ECM Turnover.
Alcoholism: Clinical and Experimental
Research, 34(11), 1-15. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19860812">[More Information]</a>
Morley, K., Teesson, M., Sannibale, C., Baillie,
A., Haber, P. (2010). Clinical Predictors of
Outcome from an Australian Pharmacological
Relapse Prevention Trial. Alcohol and
Alcoholism, 45, 520-526. <a
href="http://dx.doi.org/10.1093/alcalc/agq068">[
More Information]</a>
Dore, G., Hellard, M., Matthews, G., Grebely, J.,
Haber, P., Petoumenos, K., Yeung, B., Marks, P.,
van Beek, I., McCaughan, G., et al (2010).
Effective Treatment of Injecting Drug Users
With Recently Acquired Hepatitis C Virus
Infection. Gastroenterology, 138(1),
123-135.e1-2. <a
href="http://dx.doi.org/10.1053/j.gastro.2009.09.
019">[More Information]</a>
Boonwaat, L., Haber, P., Levy, M., Lloyd, A.
(2010). Establishment of a successful assessment
and treatment service for Australian prison
inmates with chronic hepatitis C. Medical
Journal of Australia, 192(9), 496-500. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20438418">[More Information]</a>
Grebely, J., Petoumenos, K., Matthews, G.,
Haber, P., Marks, P., Lloyd, A., Kaldor, J., Dore,
G., Hellard, M. (2010). Factors associated with
uptake of treatment for recent hepatitis C virus
infection in a predominantly injecting drug user
cohort: The ATAHC Study. Drug and Alcohol
Dependence, 107(40239), 244-249. <a
href="http://dx.doi.org/10.1016/j.drugalcdep.200
9.09.015">[More Information]</a>
Sanson-Fisher, R., Brand, M., Shakeshaft, A.,
Haber, P., Day, C., Conigrave, K., Mattick, R.,
Lintzeris, N., Teesson, M. (2010). Forming a
national multicentre collaboration to conduct
clinical trials: increasing high-quality research in
the drug and alcohol field. Drug and Alcohol
Review, 29(5), 469-474. <a
href="http://dx.doi.org/10.1111/j.1465-3362.200
9.00166.x">[More Information]</a>
Dolan, K., Teutsch, S., Scheuer, N., Levy, M.,
Rawlinson, W., Kaldor, J., Lloyd, A., Haber, P.
(2010). Incidence and risk for acute hepatitis C
infection during imprisonment in Australia.
European Journal Of Epidemiology, 25(2),
143-148. <a
href="http://dx.doi.org/10.1007/s10654-009-942
1-0">[More Information]</a>
Teutsch, S., Luciani, F., Scheuer, N., McCredie,
L., Hosseiny, P., Rawlinson, W., Kaldor, J.,
Dore, G., Dolan, K., Ffrench, R., Haber, P., et al
(2010). Incidence of primary hepatitis C
Publications for Paul Haber
infection and risk factors for transmission in an
Australian prisoner cohort. BMC Public Health,
10(633), 1-9. <a
href="http://dx.doi.org/10.1186/1471-2458-10-6
33">[More Information]</a>
Seth, D., Daly, A., Haber, P., Day, C. (2010).
Patatin-like phospholipase domain containing 3:
a case in point linking genetic susceptibility for
alcoholic and nonalcoholic liver disease.
Hepatology, 51(4), 1463-1465. <a
href="http://dx.doi.org/10.1002/hep.23606">[Mo
re Information]</a>
Teesson, M., Hall, W., Slade, T., Mills, K.,
Grove, R., Mewton, L., Baillie, A., Haber, P.
(2010). Prevalence and correlates of DSM-IV
alcohol abuse and dependence in Australia:
findings of the 2007 National Survey of Mental
Health and Wellbeing. Addiction, 105(12),
2085-2094. <a
href="http://dx.doi.org/10.1111/j.1360-0443.201
0.03096.x">[More Information]</a>
Baillie, A., Stapinski, L., Crome, E., Morley, K.,
Sannibale, C., Haber, P., Teesson, M. (2010).
Some new directions for research on
psychological interventions for comorbid anxiety
and substance use disorders. Drug and Alcohol
Review, 29(5), 518-524. <a
href="http://dx.doi.org/10.1111/j.1465-3362.201
0.00206.x">[More Information]</a>
Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor,
H., Day, C., Haber, P. (2010). The outcome of a
rapid hepatitis B vaccination programme in a
methadone treatment clinic. Addiction, 105(2),
329-334. <a
href="http://dx.doi.org/10.1111/j.1360-0443.200
9.02765.x">[More Information]</a>
2009
Haber, P., Neasham, K. (2009). Alcohol and
Drug Abuse. In T Declan Walsh, Augusto T
Caraceni, etal (Eds.), Palliative Medicine (2009),
(pp. 451-458). United States: Saunders Elsevier.
Matthews, G., Hellard, M., Haber, P., Yeung, B.,
Marks, P., Baker, D., McCaughan, G.,
Sasadeusz, J., White, P., Rawlinson, W., et al
(2009). Characteristics and treatment outcomes
among HIV-infected individuals in the
Australian trial in acute hepatitis C. Clinical
Infectious Diseases, 48(5), 650-658. <a
href="http://dx.doi.org/10.1086/596770">[More
Information]</a>
Leong, M., Murnion, B., Haber, P. (2009).
Examination of Opioid Prescribing in Australia
from 1992-2007. Internal Medicine Journal,
39(10), 676-681. <a
href="http://dx.doi.org/10.1111/j.1445-5994.200
9.01982.x">[More Information]</a>
Colagiuri, B., Morley, K., Boakes, R., Haber, P.
(2009). Expectancy in double-blind
placebo-controlled trials: an example from
alcohol dependence. Psychotherapy and
Psychosomatics, 78(3), 167-171. <a
href="http://dx.doi.org/10.1159/000206871">[M
ore Information]</a>
Haber, P., Lintzeris, N., Proude, E., Lopatko,, O.
(2009). Guidelines for the Treatment of Alcohol
Problems, Publications Number: P3 -5625, (pp.
vii - 232). Canberra, Australia: Commonwealth
Department of Health and Ageing.
Haber, P., Demirkol, A., Lange, K., Murnion, B.
(2009). Management of injecting drug users
admitted to hospital. The Lancet, 374(9697),
1284-1293. <a
href="http://dx.doi.org/10.1016/S0140-6736(09)
61036-9">[More Information]</a>
Day, C., Haber, P. (2009). Managing drug
dependence in people with hepatitis C. In G.
Dore, M. Temple-Smith, A. Lloyd (Eds.),
Hepatitis C: An Expanding Perspective, (pp.
288-307). East Hawthorn, Victoria: IP
Communications.
Haber, P., Lintzeris, N., Morley, K. (2009).
Pharmacotherapies for alcohol dependence. In
Paul Haber, Elizabeth Proude, Nick Lintzeris &
Olga Lopatko (Eds.), Guidelines for the
Treatment of Alcohol Problems, (pp. 93-106).
Australia: Commonwealth of Australia.
Morley, K., Teesson, M., Sannibale, C., Haber,
P. (2009). Sample bias from different recruitment
strategies in a randomised
controlled trial for alcohol dependence. Drug
and Alcohol Review, 28(3), 222-229. <a
href="http://dx.doi.org/10.1111/j.1465-3362.200
8.00022.x">[More Information]</a>
Haber, P., Addolorato, G., Russell, M., Albano,
E., Wands, J., Leggio, L. (2009). Understanding
and Treating Patients With Alcoholic Cirrhosis:
An Update. Alcoholism: Clinical and
Experimental Research, 33(7), 1136-1144. <a
href="http://dx.doi.org/10.1111/j.1530-0277.200
9.00956.x">[More Information]</a>
2008
Devanshi, S., Hogg, P., Gorrell, M., McCaughan,
G., Haber, P. (2008). Direct effects of alcohol on
hepatic fibrinolytic balance: implications for
alcoholic liver disease. Journal of Hepatology,
48(4), 614-627. <a
href="http://dx.doi.org/10.1016/j.jhep.2007.12.0
15">[More Information]</a>
Richardson, K., Baillie, A., Reid, S., Morley, K.,
Teesson, M., Sannibale, C., Weltman, M., Haber,
P. (2008). Do acamprosate or naltrexone have an
effect on daily drinking by reducing craving for
alcohol? Addiction, 103(6), 953-959. <a
Publications for Paul Haber
href="http://dx.doi.org/10.1111/j.1360-0443.200
8.02215.x">[More Information]</a>
Gong, M., Castillo, L., Redman, R., Garige, M.,
Hirsch, K., Azuine, M., Amdur, R., Seth, D.,
Haber, P., Lakshmanan, M. (2008).
Down-regulation of liver Galβ1, 4GlcNAc α2,
6-sialyltransferase gene by ethanol significantly
correlates with alcoholic steatosis in humans.
Metabolism: Clinical and Experimental, 57(12),
1663-1668. <a
href="http://dx.doi.org/10.1016/j.metabol.2008.0
7.021">[More Information]</a>
Sydney public hospitals after naltrexone
implants. Medical Journal of Australia, 188(8),
441-444. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18429708">[More Information]</a>
2007
Proude, E., Conigrave, K., Britton, A., Haber, P.
(2008). Improving alcohol and tobacco history
taking by junior medical officers. Alcohol and
Alcoholism, 43(3), 320-325. <a
href="http://dx.doi.org/10.1093/alcalc/agm182">
[More Information]</a>
Wurst, F., Haber, P., Wiesbeck, G., Watson, B.,
Wallace, C., Whitfield, J., Halter, C., Weinmann,
W., Conigrave, K. (2007). Assessment of alcohol
consumption among hepatitis C-positive people
receiving opioid maintenance treatment using
direct ethanol metabolites and self-report: a pilot
study. Addiction Biology,
doi:10.1111/j.1369-1600.2007.00076.x, 1-7. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17711559">[More Information]</a>
Neuman, M., Sha, K., Esguerra, R., Zakhari, S.,
Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C.,
Seth, D., Gorrell, M., Haber, P., McCaughan, G.,
et al (2008). Inflammation and Repair in Viral
Hepatitis C. Digestive Diseases and Sciences,
53(6), 1468-1487. <a
href="http://dx.doi.org/10.1007/s10620-007-004
7-3">[More Information]</a>
Shourie, S., Conigrave, K., Proude, E., Haber, P.
(2007). Detection of and intervention for
excessive alcohol and tobacco use among adult
hospital in-patients. Drug and Alcohol Review,
26(2), 127-133. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17364847">[More Information]</a>
Thomson, C., Morley, K., Teesson, M.,
Sannibale, C., Haber, P. (2008). Issues with
recruitment to randomised controlled trials in the
drug and alcohol field: a literature review and
Australian case study. Drug and Alcohol Review,
27(2), 115-122. <a
href="http://dx.doi.org/10.1080/0959523070182
9561">[More Information]</a>
Addolorato, G., Leggio, L., Ferrulli, A., Cardone,
S., Vonghia, L., Mirijello, A., Abenavoli, L.,
D’Angelo, C., Caputo, F., Haber, P., et al (2007).
Effectiveness and safety of baclofen for
maintenance of alcohol abstinence in
alcohol-dependent patients with liver cirrhosis:
randomised, double-blind controlled study. The
Lancet, 370(9603), 1915-1922.
Lane, J., Proude, E., Conigrave, K., de Boer, J.,
Haber, P. (2008). Nurse-provided screening and
brief intervention for risky alcohol consumption
by sexual health clinic patients. Sexually
Transmitted Infections, 84(7), 524-527. <a
href="http://dx.doi.org/10.1136/sti.2008.032482"
>[More Information]</a>
Watson, B., Conigrave, K., Wallace, C.,
Whitefield, J., Wurst, F., Haber, P. (2007).
Hazardous alcohol consumption and other
barriers to antiviral treatment among hepatitis C
positive people receiving opioid maintenance
treatment. Drug and Alcohol Review, 26(3),
231-239. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17454012">[More Information]</a>
Dore, G., Haber, P. (2008). Tell me it ain't so:
Patient-to-patient transmission of hepatitis C in
an endoscopy clinic. Hepatology (Baltimore
Md.), 48(4), 1333-5. <a
href="http://dx.doi.org/10.1002/hep.22595">[Mo
re Information]</a>
Williams, G., Daly, M., Proude, E., Kermode, S.,
Davis, M., Barling, J., Haber, P. (2008). The
influence of alcohol and tobacco use in
orthopaedic inpatients on complications of
surgery. Drug and Alcohol Review, 27(1), 55-64.
<a
href="http://dx.doi.org/10.1080/0959523070171
1108">[More Information]</a>
Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J.,
Haber, P. (2008). Unplanned admissions to two
Shourie, S., Conigrave, K., Proude, E., Ward, J.,
Wutzke, S., Haber, P. (2007). Pre-operative
screening for excessive alcohol consumption
among patients scheduled for elective surgery.
Drug and Alcohol Review, 26(2), 119-125. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17364846">[More Information]</a>
Haber, P., Young, M., Dorrington, L., Jones, A.,
Kaldor, J., De Kanzow, S., Rawlinson, W.
(2007). Transmission of hepatitis C virus by
needle-stick injury in community settings.
Journal of Gastroenterology and Hepatology,
22, 1882-1885. <a
Publications for Paul Haber
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17914964">[More Information]</a>
Haber, P., McCaughan, G., Shaw, D., Matthews,
G., Hellard, M., Dore, G., Lloyd, A., Kaldor, J.,
Rowlinson, W., Ffrench, R. (2007). Treatment of
recently acquired hepatitis C infection in
injecting drug users: Preliminary results from the
australian trial in acute hepatitis C (ATAHC).
The 58th Annual Meeting of the American
Association for the Study of Liver Diseases,
United States of America: John Wiley & Sons.
2006
Haber, P. (2006). Commentary: Challenge for
doctors and policy makers. BMJ: British Medical
Journal, 332, 277-278.
Proude, E., Conigrave, K., Haber, P. (2006).
Effectiveness of skills-based training using the
Drink-less package to increase family
practitioner confidence in intervening for alcohol
use disorders. BMC International Health and
Human Rights, 6(8), 1-6. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16457737">[More Information]</a>
Seth, D., Hogg, P., Gorrell, M., McCaughan, G.,
Haber, P. (2006). Identification of novel
therapeutic targets for alcoholic liver disease.
International Society for Biomedical Research
on Alcoholism World congress on Alcohol
Research (ISBRA 2006), Maryland:
Wiley-Blackwell Publishing.
Seth, D., Gorrell, M., Cordoba, S., McCaughan,
G., Haber, P. (2006). Intrahepatic gene
expression in human alcoholic hepatitis. Journal
of Hepatology, 45(2), 306-320. <a
href="http://dx.doi.org/10.1016/j.jhep.2006.04.0
13">[More Information]</a>
Morley, K., Teesson, M., Reid, S., Sannibale, C.,
Thomson, C., Phung, N., Weltman, M., Bell, J.,
Richardson, K., Haber, P. (2006). Naltrexone
versus acamprosate in the treatment of alcohol
dependence: a multi-centre, randomized,
double-blind, placebo-controlled trial. Addiction,
101(10), 1451-1462. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16968347">[More Information]</a>
Seth, D., Beard, M., Gorrell, M., McCaughan,
G., Haber, P. (2006). Osteopontin: An early
marker for alcoholic liver injury? Alcoholism:
Clinical and Experimental Research, 30(s2),
89A-89A.
Kelly, M., Chick, J., Gribble, R., Gleeson, M.,
Holton, M., Winstanley, J., McCaughan, G.,
Haber, P. (2006). Predictors of relapse to harmful
alcohol after orthotopic liver transplantation.
Alcohol and Alcoholism, 41(3), 278-283.
Shourie, S., Conigrave, K., Proude, E., Ward, J.,
Wutzke, S., Haber, P. (2006). The Effectiveness
of a Tailored Intervention for Excessive Alcohol
Consumption Prior to Elective Surgery. Alcohol
and Alcoholism, 41(6), 643-649. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16905552">[More Information]</a>
Richardson, K., Reid, S., Morley, K., Teesson,
M., Sannibale, C., Weltman, M., Baillie, A.,
Haber, P. (2006). The effects of alcohol and
naltrexone on craving and alcohol consumption.
Alcoholism: Clinical and Experimental
Research, 30(s2), 169A-169A.
Shackel, N., Seth, D., Haber, P., Gorrell, M.,
McCaughan, G. (2006). The hepatic
transcriptome in human liver disease.
Comparative Hepatology, 5, 6-6. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17090326">[More Information]</a>
Teesson, M., Morley, K., Reid, S., Sannibale, C.,
Thomson, C., Richardson, K., Haber, P. (2006).
The influence of depression on pharmacotherapy
for alcohol dependence. Alcoholism: Clinical
and Experimental Research, 30(s2), 68A-68A.
2005
Watson, B., Haber, P., Conigrave, K., Whitfield,
J., Wallace, C., Wurst, F. (2005). Alcohol
consumption patterns amongst hepatitis C
positive people receiving opioid maintenance
treatment. Alcoholism: Clinical and
Experimental Research, 29(S1), 32A-32A.
Wurst, F., Watson, B., Haber, P., Whitfield, J.,
Wallace, C., Lauer, J., Weinmann, W.,
Conigrave, K. (2005). Alcohol consumption
patterns amongst hepatitis C positive people
receiving opioid maintenance treatment. 24th
Symposium of the Arbeitsgemeinschaft fur
Neuropsychopharmakologie und
Pharmakopsychiatrie, Germany: Georg Thieme
Verlag.
Shourie, S., Haber, P., Boughton, R., Conigrave,
K. (2005). Clinical implications of alcohol
misuse for surgery. In Preedey V; Watson R
(Eds.), Comprehensive handbook of alcohol
related pathology, (pp. 337-348). United States:
Academic Press.
Seitz, H., Salaspuro, M., Savolainen, M., Haber,
P., Ishii, H., Teschke, R., Moshage, H., Lieber,
C. (2005). From alcohol toxicity to treatment.
Alcoholism: Clinical and Experimental
Research, 29(7), 1341. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16088998">[More Information]</a>
Publications for Paul Haber
Conigrave, K., Proude, E., Haber, P., Wilson, H.,
Saunders, J. (2005). How to treat - alcohol
problems. Australian Doctor, 35(9), 35-42.
Reid, S., Teesson, M., Sannibale, C., Matsuda,
M., Haber, P. (2005). The Efficacy of
Compliance Therapy in Pharmacotherapy for
Alcohol Dependence: A Randomized Controlled
Trial. Journal of Studies on Alcohol, 66(6),
833-841.
Theodorou, S., Haber, P. (2005). The medical
complications of heroin use. Current Opinion in
Psychiatry, 18(3), 257-263.
and referral practices in managing patients with
drug and alcohol-related health problems:
implications for medical training and education
programmes. Drug and Alcohol Review, 22(4),
417-424.
Haber, P., Conigrave, K., Wodak, A. (2003).
NSW Alcohol Summit: getting a better grip on
our favourite drug. Medical Journal of Australia,
11, 521-522.
2004
Haber, P., Warner, R., Seth, D., Gorrell, M.,
McCaughan, G. (2003). Pathogenesis and
management of alcoholic hepatitis. Journal of
Gastroenterology and Hepatology, 18(12),
1332-1344.
Post, J., Pan, Y., Freeman, A., Harvey, C.,
White, P., Palladinetti, P., Haber, P., Marinos,
G., Levy, M., Kaldor, J., et al (2004). Clearance
Of Hepatitis C Viremia Associated With Cellular
Immunity In The Absence Of Seroconversion In
The Hepatitis C Incidence And Transmission In
Prisons Study Cohort. The Journal of Infectious
Diseases, 189(10), 1846-1855.
Seth, D., Gorrell, M., McGuiness, P., Leo, M.,
Lieber, C., McCaughan, G., Haber, P. (2003).
SMART amplification maintains representation
of relative gene expression: quantitative
validation by real time PCR and application to
studies of alcoholic liver disease in primates.
Journal Of Biochemical and Biophysical
Methods, 55(1), 53-66.
Proude, E., Shourie, S., Conigrave, K., Wutzke,
S., Haber, P., Ward, J. (2004). Do Elective
Surgery Patients Use The Internet To Look For
Information About Their Condition? ANZ
Journal of Surgery, 74(5), 304-307.
Conigrave, K., Davies, P., Haber, P., Whitfield,
J. (2003). Traditional markers of excessive
alcohol use. Addiction, 98(S2), 31-43.
Haber, P. (2004). Genetic disorders in
pancreatitis. Journal of Gastroenterology and
Hepatology, 19(8), 939-939. <a
href="http://dx.doi.org/10.1111/j.1440-1746.200
4.03571.x">[More Information]</a>
Haber, P., Nakamura, M., Tsuchimoto, K., Ishii,
H., Keogh, G., Apte, M., Moran, C., Stewart, N.,
Crawford, D., Pirola, R., McCaughan, G.,
Ramm, G., Conigrave, K., et al (2001). Alcohol
and the pancreas. Alcoholism: Clinical and
Experimental Research, 25, 244S-250S.
Gates, J., Post, J., Kaldor, J., Pan, Y., Haber, P.,
Lloyd, A., Dolan, K. (2004). Risk Factors For
Hepatitis C Infection And Perception Of
Antibody Status Among Male Prison Inmates In
The Hepatitis C Incidence And Transmission In
Prisons Study Cohort, Australia. Journal of
Urban Health, 81(3), 448-452.
2003
Post, J., Yong, W., Freeman, A., Harvey, C.,
White, P., Palladinetti, P., Marinos, G., Haber,
P., Levy, M., Kaldor, J., et al (2003). Clearance
of Hepatitis C viremia associated with cellular
immunity in the absence of seroconversion in the
Hepatitis C incidence and transmission in prisons
study cohort. The Journal of Infectious Diseases,
11, 1846-1855.
Seth, D., Leo, M., McGuinness, P., Lieber, C.,
Brennan, Y., Williams, R., Wang, X.,
McCaughan, G., Gorrell, M., Haber, P. (2003).
Gene expression profiling of alcoholic liver
disease in the Baboon (Papio hamadryas) and
human liver. The American Journal of
Pathology, 163(6), 2303-2317.
Fucito, L., Gomes, B., Murnion, B., Haber, P.
(2003). General practitioners' diagnostic skills
2001